MDS Pharma Services Announces Sponsorship of Alex’s Lemonade Stand Foundation

November 13, 2007 - MDS Pharma Services, has become a major corporate sponsor of the Alex's Lemonade Stand Foundation and its work to fight childhood cancer.

MDS Pharma Services Launches New Brand Campaign to Support Client Service Strategy

November 12, 2007 - MDS Pharma Services, has launched a new brand promise - "to deliver high-quality services on-time" - as part of their strategic plan to become the industry leader in quality, compliance and client service

MDS Pharma Services Expands Central Lab Operations in China

October, 30, 2007 - MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, announced today a significant expansion of its central lab operations in China. The contract research organization has moved to a new, larger facility in Beijing to meet the growing demands from pharmaceutical and biotech companies conducting clinical trials in China.

MDS Pharma Services Wins Award for Management of Global Malaria Trial

September 7, 2007 - MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, has won the Good Clinical Practice Journal (GCPj) Award for the clinical research program that best promotes access to new medicines. This award is one of a series of inaugural GCPj awards introduced this year to recognize excellence in clinical research. MDS Pharma Services received this award during a ceremony in London where it was recognized for its successful management of a large-scale Phase III malaria drug trial involving more than 2,700 patients in Laos, India, Thailand, Burkina Faso, Kenya, Mozambique, Uganda, and Zambia.

MDS Pharma Services Expands Development & Regulatory Services in Europe

August 1, 2007 - MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, announced today the expansion of its Development & Regulatory Services (DRS) business in Europe. MDS Pharma Services will now offer full-service DRS consulting services to support development of new drugs and biopharmaceutical products for clients in Europe.

MDS Pharma Services Hires Howard Moody as Vice-President of Information Technology

Jun 21, 2007 - MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, has named Howard Moody to the position of Vice-President of Information Technology (IT). In this role, Mr. Moody will be responsible for implementing effective IT applications to improve processes, increase operational efficiencies and fuel business growth in MDS Pharma Services. Mr. Moody will report to MDS Pharma Services President David Spaight and MDS Inc. Chief Information Officer (CIO) Tom Gernon.

Dr. Todd Johnson Joins MDS Pharma Services as Senior Vice-President for Strategy and Corporate Development

May 31, 2007 - MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, has named Dr. Todd Johnson to the position of Senior Vice-President for Strategy and Corporate Development. Dr. Johnson will lead efforts to accelerate profitable growth through strategic partnerships and acquisitions.

MDS Pharma Services Names Dr. James Pusey to Lead Global Clinical Development

May 11, 2007 - MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, has appointed Dr. James M. Pusey as Vice-President and General Manager of its Global Clinical Development business, which manages late-stage clinical drug trials. Dr. Pusey brings more than 25 years of experience in medicine, global clinical trial management, contract research organization services, and global pharmaceutical sales, marketing and operations.

MDS Finalizes Sale of Diagnostics Business to Borealis Infrastructure in $1.3B Transaction

February 26, 2007 - MDS Inc. (TSX: MDS; NYSE: MDZ), a global life sciences company, announced today that it has concluded the sale of its Canadian laboratory services business, MDS Diagnostic Services, to Borealis Infrastructure Management Inc. in a CAD$1.325 billion transaction.

FDA Clarifies Path to Review Completion for MDS Bioanalytical Clients

January 10, 2007 - MDS Inc. (TSX:MDS)(NYSE:MDZ), a company providing a range of products and services to the global life sciences markets, announced that the Food and Drug Administration (FDA) today outlined a path that will enable MDS and its clients to bring closure to the agency's review of bioanalytical studies conducted at the Company's St. Laurent and Blainville, Quebec, Canada facilities from January 2000 through December 2004.